The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy is modestly affected...
Scientists hope that a new approach to vaccine development, combined with improved surveillance of potential future threats of outbreak, could help to...